al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer - a GERCOR study. - Tournigand,C.; Cervantes,A.; Figer,A.; et,. (J Clin Oncol, 2006)